Formats
  1. Journal Article (66881)
  2. Meeting Abstract (33621)
  3. Book Section (5097)
  4. Review (3755)
  5. Editorial (2168)
  6. Conference Paper (1526)
  7. Correspondence (665)
  8. Guidelines (662)
  9. Research Letter (548)
  10. Book Whole (344)
  11. Miscellaneous (339)
Groups
  1. Department of Medicine (39053)
  2. GSK Faculty (22471)
  3. Solid Tumor Oncology Division (22069)
  4. Surgery (21267)
  5. Survivorship Research (15771)
  6. Sloan Kettering Institute Faculty (15654)

More Groups

People
  1. Marc Ladanyi (1328)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1051)

More People

Years
  1. 2025 (2138)
  2. 2024 (5384)
  3. 2023 (5806)
  4. 2022 (6169)
  5. 2021 (5714)
  6. 2020 (5618)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4951)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2611)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13846)
  2. American Society of Clinical Oncology (9169)
  3. Springer (7193)
  4. Nature Publishing Group (6375)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5512)

More Publishers

Results (115606)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adolescent and young adults with ALL who complete therapy on DFCI Consortium ALL trials have excellent long-term overall survival
    Meeting Abstract

    Valtis, Y. K.; Flamand, Y.; Shimony, S.; Place, A. E.; Silverman, L. B.; Vrooman, L. M.; Brunner, A. M.; Sallan, S. E.; Wadleigh, M.; Stone, R. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of allelic state on overall survival in TP53-mutant acute myeloid leukemia (AML) and higher risk myelodysplastic syndromes (HR-MDS)
    Meeting Abstract

    Bewersdorf, J. P.; Hasle, V.; Shallis, R. M.; Thompson, E. G.; de Menezes, D. L.; Rose, S.; Boss, I. W.; Halene, S.; Haferlach, T.; Fox, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Umbrella trial in myeloid malignancies: The myelomatch national clinical trials network precision medicine initiative
    Meeting Abstract

    Little, R. F.; Othus, M.; Assouline, S.; Ansher, S.; Atallah, E. L.; Lindsley, R. C.; Freidlin, B.; Gore, S. D.; Harris, L.; Hourigan, C. S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase II clinical trial of E7820 for patients with relapsed/refractory myeloid malignancies with mutations in splicing factor genes
    Meeting Abstract

    Bewersdorf, J. P.; Stahl, M. F.; Taylor, J.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Kostantakis, V.; Lu, S. X.; Bourcier, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Trends in collection and utilization of autologous hematopoietic stem cells (APBHC) intended for transplant in patients with multiple myeloma
    Meeting Abstract

    Samuel, N.; Laufer, L.; Tanaguchi, R.; Rosiene, J.; Palesi, C.; Elkind, R.; Mantzaris, I.; Shastri, A.; Kornblum, N.; Sica, R. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A timelapse of patient and provider care perceptions and educational needs for CLL over three years of tailored educational interventions
    Meeting Abstract

    Ackbarali, T.; O'Brien, S.; Mato, A. R.; Davids, M. S.
    Blood (2022)

    Fulltext@MSK | Save
  • The AP-1/ETS transcription factor network regulates stem cell quiescence and chemotherapy resistance in acute myeloid leukemia
    Meeting Abstract

    Takao, S.; Morell, V.; Brown, F. C.; Koche, R.; Kentsis, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Cohesin dependency in NPM1(c/+) and FLT3-ITD mutant hematopoietic stem and progenitor cells
    Meeting Abstract

    Xu, J. J.; Alija, B.; Braunstein, S.; Pantazi, J.; Sudunagunta, V. S.; Bowman, R. L.; Viny, A. D.
    Blood (2022)

    Fulltext@MSK | Save
  • Precision targeting of MYD88 mutant DLBCL using the novel combination of irakimids and BCL2 inhibition
    Meeting Abstract

    Grilo, A. M.; Klaus, C.; McDonald, A.; Gollob, J.; Weiss, M.; O'Connor, O. A.; Salles, G.; Chaudhuri, J.; Lue, J. K.
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 2/3, randomized, double blind, placebo-controlled, multicenter study of NKTR-255 vs placebo following CD-19 directed CAR-T therapy in patients with relapsed/refractory large B-cell lymphoma
    Meeting Abstract

    Perales, M. A.; Ahmed, S.; Dahiya, S.; Riedell, P. A.; McGuirk, J. P.; Oluwole, O. O.; Chaudhry, S. A.; Lee, Z.; Dai, S.; Dixit, N.; more...
    Blood (2022)

    Fulltext@MSK | Save